


Certificate of Analysis
Independent analysis of this lot by Kovera Labs (HPLC-UV).
- Purity
- 99.67%
- Lot
- ML-260912
- Tested Most recent
- Sep 2026
GLOW Peptide Blend
Blend
In Stock- Form
- Lyophilized powder
- Purity (HPLC)
- 99.67% HPLC-UV
- Storage
- -20°C or colder
- Lot / COA
- BPC-15710mg
- GHK-Cu50mg
- TB-50010mg

- Free shippingOn every order
- Free 2nd Day AirOn orders $200+
Research Use Only
For laboratory research use only. Not for human consumption. All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Specifications
- Composition
- BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg
- Form
- Lyophilized powder
- Purity (HPLC)
- 99.67% HPLC-UV
- Storage
- -20°C or colder
- Lot / COA
Certificate of Analysis
Independent analysis of this lot by Kovera Labs (HPLC-UV).
- Purity
- 99.67%
- Lot
- ML-260912
- Tested Most recent
- Sep 2026
GLOW Peptide Blend Overview
The GLOW peptide blend combines three synthetic peptides — GHK-Cu, BPC-157, and TB-500 — in a single 70mg formulation. Each constituent has been studied individually in laboratory and preclinical research contexts, where these peptides have been investigated separately for their influence on angiogenesis, extracellular matrix remodeling, and systemic signaling pathways.
KLOW is a related Medicina Labs research formulation containing the same three constituents together with KPV.
For how this formulation differs from KLOW in composition, see GLOW vs KLOW.
History
The concept of the GLOW Blend arises from decades of research into individual signaling peptides. GHK-Cu was first identified in biological plasma samples in the 1970s and later studied for gene regulation and matrix remodeling activity. BPC-157 was synthesized in the 1990s as a gastric protein fragment analog and has since been researched for angiogenic and structural processes. TB-500, the synthetic thymosin beta-4 sequence, traces its research lineage to thymus peptide studies in the 1960s and is recognized for its effects on molecular migration and angiogenesis. Combined, these peptides represent a convergence of experimental research lines.
GHK-Cu Structure
CAS #: 89030-95-5
Molecular Formula: C14H23CuN6O4+
Molecular Weight: 402.92 g/mol
PubChem ID: 71587328
BPC-157 Structure
CAS #: 137525-51-0
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.5 g/mol
PubChem ID: 9941957
TB-500 Structure
CAS #: 77591-33-4
Molecular Formula: C212H350N56O78S
Molecular Weight: 4963.5 g/mol
Research Findings
The individual constituents of the GLOW Blend — GHK-Cu, BPC-157, and TB-500 — have been studied separately in laboratory and preclinical research contexts, including structural, epithelial, vascular, and systemic models. That research has examined collagen organization, molecular migration, angiogenesis, and molecular signaling.
Key Areas of Research:
- Structural: Collagen, matrix, tendon/ligament
- Epithelial: Migration, matrix signaling, follicle dynamics
- Vascular: Angiogenesis, nitric oxide, formation
- Systemic: Signaling, viability, pathway dynamics
These findings relate to the individual constituents; the studies cited on this page did not examine the finished GLOW Blend.
Analytically, the three constituents differ substantially in size and class: GHK-Cu is a copper-coordinated tripeptide (402.92 g/mol), BPC-157 is a 15-amino-acid linear peptide (1419.5 g/mol), and TB-500 is listed at 4963.5 g/mol. These differences in molecular weight and composition are relevant to chromatographic separation and identity characterization of a multi-component formulation.
References
Our Process
Precision Lyophilization
Each batch is freeze-dried and sealed for stability until reconstitution.
Verified Purity
Every batch is third-party tested with HPLC and mass spectrometry.
Careful Fulfillment
Orders ship within 24 hours from our U.S. facility.
